Is it prime time to consider a clinical trial of doxycycline for the management of COVID-19?

Milionis, Haralampos; Kostikas, Konstantinos

Milionis, Haralampos; Kostikas, Konstantinos.

Milionis H; Department of Internal Medicine, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Kostikas K; Respiratory Medicine Department, Faculty of Medicine, University of Ioannina, Ioannina, Greece ktkostikas@gmail.com.

Postgrad Med J ; 98(e2): e107, 2022 03.

Article in English | MEDLINE | ID: covidwho-961132

Subject(s)

COVID-19 Drug Treatment; Doxycycline; Doxycycline/therapeutic use; Humans; SARS-CoV-2

Keywords

COVID-19; infection control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Doxycycline / COVID-19 Drug Treatment Type of study: Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Postgrad Med J Year: 2022 Document Type: Article Affiliation country: Postgradmedj-2020-139358

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google